Sign up here to receive news updates via email.
-
December 3, 2024 |
News and Updates, Media, Uncategorized
BPGbio named Amongst Ten Companies to Watch in AI Drug Discovery in GEN Article!
read more -
November 21, 2024 |
Media, News and Updates, Press Releases
BPGbio to Present New Data on Novel Glioblastoma Therapies at SNO 2024
read more -
November 19, 2024 |
Media, News and Updates, Press Releases
BPGbio Recognized as 2024 ‘BioTech AI Company of the Year’ by BioTech Breakthrough Awards
read more -
November 12, 2024 |
Media, News and Updates, Press Releases
BPGbio to Present on Chemical Proteomics Technologies to Enable E2-based Targeted Protein Degradation at Hit ID Summit
read more -
November 7, 2024 |
Media, News and Updates, Press Releases
BPGbio to Present Transformative Immuno-Oncology Research on BPM31510 and BRG399 at SITC 2024
read more -
October 31, 2024 |
Media, News and Updates, Press Releases
BPGbio Receives FDA Rare Pediatric Disease Designation for its Investigational Treatment for Epidermolysis Bullosa
read more
